Immunotherapy for recurrent or metastatic head and neck squamous cell carcinoma
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three experts as they explore key clinical considerations when using immune checkpoint inhibitors to treat recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). The discussion includes the current role of immune checkpoint inhibitors, factors that may inform treatment decisions and approaches for managing side effects associated with immune checkpoint inhibitors.
The experts
Prof. Kevin Harrington – The Institute of Cancer Research, London, UK
Prof. Barbara Burtness – Yale Cancer Center, New Haven, CT, USA
Prof. Jean-Pascal…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.